Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · June 27, 2023

Association of Prescription Co-Payment With Adherence to GLP-1 Receptor Agonist and SGLT2 Inhibitor Therapies in Patients With Heart Failure and Diabetes

JAMA Network Open


Additional Info

Disclosure statements are available on the authors' profiles:

JAMA Network Open
Association of Prescription Co-payment With Adherence to Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter-2 Inhibitor Therapies in Patients With Heart Failure and Diabetes
JAMA Netw Open 2023 Jun 01;6(6)e2316290, UR Essien, B Singh, G Swabe, AE Johnson, LA Eberly, RK Wadhera, K Breathett, M Vaduganathan, JW Magnani

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading